Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flebogamma 10% DIF in Chronic ITP
NCT00511147Phase 3Completed
- Sponsor
- Grifols
- Start
- May 2008
- Primary completion
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 3 trial of gamunex in immune thrombocytopenia (ITP), sponsored by Grifols. Started May 2008; status: completed.
02
Drugs
gamunex
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT00511147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00511147.